고바야시 제약 주식회사: 손익 계산서 (TTM)

고바야시 제약 주식회사
JP ˙ TSE ˙ JP3301100008
JP¥5,627.00 ↓ -53.00 (-0.93%)
2026-06-04
주가
손익 계산서 (TTM)

고바야시 제약 주식회사 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
수익 151,386 153,123 155,252 157,629 159,464 161,873 166,258 167,079 168,619 171,094 173,455 176,473 172,966 168,799 165,600 161,722 161,482 163,179 165,742 166,800
변화 (%) 1.15 1.39 1.53 1.16 1.51 2.71 0.49 0.92 1.47 1.38 1.74 -1.99 -2.41 -1.90 -2.34 -0.15 1.05 1.57 0.64
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 64,926 65,707 66,478 68,007 69,382 71,150 73,927 74,060 74,727 76,017 77,079 78,474 78,324 77,831 77,997 78,387 78,491 79,410 81,030 81,332
변화 (%) 1.20 1.17 2.30 2.02 2.55 3.90 0.18 0.90 1.73 1.40 1.81 -0.19 -0.63 0.21 0.50 0.13 1.17 2.04 0.37
수익의 % 42.89 42.91 42.82 43.14 43.51 43.95 44.47 44.33 44.32 44.43 44.44 44.47 45.28 46.11 47.10 48.47 48.61 48.66 48.89 48.76
총 영업 이익 86,460 87,416 88,774 89,622 90,082 90,723 92,331 93,019 93,892 95,077 96,376 97,999 94,642 90,968 87,603 83,335 82,991 83,769 84,712 85,468
변화 (%) 1.11 1.55 0.96 0.51 0.71 1.77 0.75 0.94 1.26 1.37 1.68 -3.43 -3.88 -3.70 -4.87 -0.41 0.94 1.13 0.89
수익의 % 57.11 57.09 57.18 56.86 56.49 56.05 55.53 55.67 55.68 55.57 55.56 55.53 54.72 53.89 52.90 51.53 51.39 51.34 51.11 51.24
판매관리비 51,429 52,491 52,188 52,891 53,879 54,856 54,065 54,537 55,090 56,165 57,611 59,271 56,817 54,624 48,191 46,419 46,318 49,700 54,205 56,129
변화 (%) 2.06 -0.58 1.35 1.87 1.81 -1.44 0.87 1.01 1.95 2.57 2.88 -4.14 -3.86 -11.78 -3.68 -0.22 7.30 9.06 3.55
수익의 % 33.97 34.28 33.62 33.55 33.79 33.89 32.52 32.64 32.67 32.83 33.21 33.59 32.85 32.36 29.10 28.70 28.68 30.46 32.70 33.65
연구개발 7,338 7,338 7,522 7,522 7,522 7,522 8,327 8,327 8,327 8,327 9,004 9,004 9,004 9,004 9,109 9,109 9,109 9,109 9,122 9,122
변화 (%) 0.00 2.51 0.00 0.00 0.00 10.70 0.00 0.00 0.00 8.13 0.00 0.00 0.00 1.17 0.00 0.00 0.00 0.14 0.00
수익의 % 4.85 4.79 4.85 4.77 4.72 4.65 5.01 4.98 4.94 4.87 5.19 5.10 5.21 5.33 5.50 5.63 5.64 5.58 5.50 5.47
운영 비용 125,563 127,406 129,301 131,533 133,896 136,641 139,752 140,357 141,577 143,942 147,828 150,883 148,279 145,593 140,890 139,508 139,511 143,812 150,897 153,123
변화 (%) 1.47 1.49 1.73 1.80 2.05 2.28 0.43 0.87 1.67 2.70 2.07 -1.73 -1.81 -3.23 -0.98 0.00 3.08 4.93 1.48
수익의 % 82.94 83.21 83.28 83.44 83.97 84.41 84.06 84.01 83.96 84.13 85.23 85.50 85.73 86.25 85.08 86.26 86.39 88.13 91.04 91.80
영업 이익 25,823 25,717 25,951 26,096 25,568 25,232 26,506 26,722 27,042 27,152 25,627 25,590 24,687 23,206 24,710 22,214 21,971 19,367 14,845 13,677
변화 (%) -0.41 0.91 0.56 -2.02 -1.31 5.05 0.81 1.20 0.41 -5.62 -0.14 -3.53 -6.00 6.48 -10.10 -1.09 -11.85 -23.35 -7.87
수익의 % 17.06 16.79 16.72 16.56 16.03 15.59 15.94 15.99 16.04 15.87 14.77 14.50 14.27 13.75 14.92 13.74 13.61 11.87 8.96 8.20
이자 비용 -21 -21 -18 -20 -18 -18 -18 -18 -20 -28 -29 -29 -35 -29 -28 -28 -23 -20 -28 -28
변화 (%) -0.00 -14.29 11.11 -10.00 -0.00 -0.00 -0.00 11.11 40.00 3.57 -0.00 20.69 -17.14 -3.45 -0.00 -17.86 -13.04 40.00 -0.00
수익의 % -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.02 -0.02
당기순이익 18,868 18,830 19,715 19,560 19,534 19,332 20,022 20,157 20,186 21,020 20,338 17,706 13,910 10,184 10,067 10,715 11,798 11,532 3,656 3,068
변화 (%) -0.20 4.70 -0.79 -0.13 -1.03 3.57 0.67 0.14 4.13 -3.24 -12.94 -21.44 -26.79 -1.15 6.44 10.11 -2.25 -68.30 -16.08
수익의 % 12.46 12.30 12.70 12.41 12.25 11.94 12.04 12.06 11.97 12.29 11.73 10.03 8.04 6.03 6.08 6.63 7.31 7.07 2.21 1.84

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:KOY €30.60
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista